Roche Holding AG has finalised its acquisition of LumiraDx’s innovative Point of Care technology, a strategic move aimed at enhancing its diagnostic portfolio and expanding global access to essential healthcare. The completion of this acquisition, following all necessary antitrust and regulatory approvals, marks a significant milestone for Roche as it integrates LumiraDx’s multi-assay point of […]
Roche has announced a definitive agreement to acquire select parts of LumiraDx Group related to its innovative Point of Care technology, a deal totaling $350 million. Expected to close by mid-2024, this acquisition is set to fully integrate the acquired entities into Roche Diagnostics, significantly expanding its diagnostics portfolio. Transforming Point of Care Testing Matt […]
Roche is teaming up with Eli Lilly and Company (Lilly) to support the development of its Elecsys Amyloid Plasma Panel (EAPP) blood test which has been designed by the former to enable the earlier diagnosis of Alzheimer’s disease. According to Roche, to deal with the strain that Alzheimer’s disease has on healthcare systems, it is […]